Bonrange-PTH Injection
Marketer
Biorange Biologicals Private Limited
Salt Composition
Teriparatide (750mcg)
Overview Bonrange-PTH Injection
Parathyroid hormone (PTH) therapy, marketed as Bonrange-PTH Injection, is a synthetic formulation indicated for treating severe osteoporosis in men and postmenopausal women at heightened fracture risk. This medication promotes bone growth, thus increasing bone mineral density and reducing the likelihood of vertebral fractures. Administration involves subcutaneous injection, either self-administered or by a medical professional. Consistent daily dosing at the same time maximizes therapeutic efficacy. Treatment typically lasts up to two years, though patients should adhere to their physician's prescribed course, regardless of symptom improvement. Refrigeration between 2°C and 8°C is essential. Commonly reported adverse effects include arthralgia, injection site inflammation (pain, edema, erythema), and leg spasms. Patients should report persistent or bothersome side effects to their doctor. Prior to commencing treatment, individuals with renal calculi or other kidney disorders should inform their physician, as hypercalcemia or hypercalciuria may occur. Pregnant or lactating women should seek medical counsel before using this medication. Regular bone density monitoring, potentially via bone scans, may be recommended by your doctor to track treatment progress.
Uses of Bonrange-PTH Injection
Brittle bone disease
Major Benefits of Bonrange-PTH Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bonrange-PTH Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Bonrange-PTH Injection:
Administering this medication will be done by your physician or their nursing staff; self-medication is strictly prohibited.
How Bonrange-PTH Injection works:
Parathyroid hormone (PTH), a naturally occurring human hormone, is mimicked by the Bonrange-PTH Injection. This synthetic PTH stimulates osteoblast function and proliferation, leading to enhanced bone strength and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Bonrange-PTH Injection alongside alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Bonrange-PTH Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on Bonrange-PTH Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administration of Bonrange-PTH Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Patients with kidney impairment should receive Bonrange-PTH Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Bonrange-PTH Injection is contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Bonrange-PTH Injection's use in individuals with hepatic impairment. Seek medical advice from your physician.
What if you forget to take Bonrange-PTH Injection :
Should you forget a Bonrange-PTH Injection, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bonrange-PTH Injection
| Label | Value |
|---|---|
| Chemical Type | Parathyroid Hormone-Related Peptides |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
3,018 People bought this recently